Publication Author: Sullivan_Sean
-
Updated evaluation of the cost-effectiveness of lung volume reduction surgery.
Ramsey SD, Shroyer AL, Sullivan SD, Wood DE. Updated evaluation of the cost-effectiveness of lung volume reduction surgery. Chest. 2007 Mar;131(3):823-32.
rakerr2
-
Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma.
Sullivan SD, Rasouliyan L, Russo PA, Kamath T, Chipps BE; TENOR Study Group. Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma. Allergy. 2007 Feb;62(2):126-33.
rakerr2
-
Pain, demographics, and clinical characteristics in persons who received hospice care in the United States.
Strassels SA, Blough DK, Hazlet TK, Veenstra DL, Sullivan SD. Pain, demographics, and clinical characteristics in persons who received hospice care in the United States. J Pain Symptom Manage. 2006 Dec;32(6):519-31.
rakerr2
-
Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002.
Zerzan JT, Morden NE, Soumerai S, Ross-Degnan D, Roughead E, Zhang F, Simoni-Wastila L, Sullivan SD. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care. 2006 Nov;44(11):1005-10.
rakerr2
-
Application of economic analyses in U.S. managed care formulary decisions: a private payer’s experience.
Watkins JB, Minshall ME, Sullivan SD. Application of economic analyses in U.S. managed care formulary decisions: a private payer’s experience. J Manag Care Pharm. 2006 Nov-Dec;12(9):726-35.
rakerr2
-
The ATTEMPT cohort: a multi-national longitudinal study of predictors, patterns and consequences of smoking cessation; introduction and evaluation of internet recruitment and data collection methods.
West R, Gilsenan A, Coste F, Zhou X, Brouard R, Nonnemaker J, Curry SJ, Sullivan SD. The ATTEMPT cohort: a multi-national longitudinal study of predictors, patterns and consequences of smoking cessation; introduction and evaluation of internet recruitment
rakerr2
-
Managing biotechnology in a network-model health plan: a U.S. private payer perspective.
Watkins JB, Choudhury SR, Wong E, Sullivan SD. Managing biotechnology in a network-model health plan: a U.S. private payer perspective. Health Aff (Millwood). 2006 Sep-Oct;25(5):1347-52.
rakerr2
-
Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study.
Weiss K, Buxton M, Andersson FL, Lamm CJ, Liljas B, Sullivan SD. Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study. Pediatr Allergy Immunol. 2006 May;17 Suppl 17:21-7.
rakerr2
-
More isn’t always better: cost-effectiveness analysis and the case for using a split-night protocol.
Kapur VK, Sullivan SD. More isn’t always better: cost-effectiveness analysis and the case for using a split-night protocol. J Clin Sleep Med. 2006 Apr 15;2(2):154-5.
rakerr2
-
Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic tests.
Ramsey SD, Veenstra DL, Garrison LP Jr, Carlson R, Billings P, Carlson J, Sullivan SD. Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic tests. Am J Manag Care. 2006 Apr;12(4):197-202.
rakerr2